2014 American Society of Hematology Annual Meeting*

December 6-9, 2014; San Francisco, California
This program provides coverage of the 2014 ASH annual meeting with Capsule Summaries and expert analysis of the most clinically relevant study results with downloadable highlights slidesets. Topics include leukemias, lymphomas, and multiple myeloma or other plasma cell disorders.
Ian W. Flinn, MD, PhD
Elias Jabbour, MD
Shaji Kumar, MD
Sagar Lonial, MD
Jeff P. Sharman, MD
B. Douglas Smith, MD

Leukemias

Elias Jabbour, MD, and B. Douglas Smith, MD, discuss the clinical relevance of key studies in AML, ALL, and CML presented at the 2014 American Society of Hematology annual meeting.

Elias Jabbour, MD B. Douglas Smith, MD Physicians: maximum of 1.75 AMA PRA Category 1 Credits Released: February 19, 2015 Expiration: February 18, 2016

In this downloadable slideset, Elias J. Jabbour, MD, and B. Douglas Smith, MD, select highlights of key studies in ALL, AML, and CML from the 2014 Annual Meeting of the American Society of Hematology.

Released: January 8, 2015

Lymphomas

In this expert analysis, Ian W. Flinn, MD, PhD, and Jeff P. Sharman, MD, discuss the most clinically relevant data on the management of lymphomas presented at the 2014 American Society of Hematology Annual Meeting.

Ian W. Flinn, MD, PhD Jeff P. Sharman, MD Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: February 18, 2015 Expiration: February 17, 2016

In this downloadable slideset, Ian W. Flinn, MD, PhD, and Jeffrey P. Sharman, MD reviews key studies and data relevant to the management of patients with lymphomas presented at the 2014 American Society of Hematology Annual Meeting.

Released: January 7, 2015

Multiple Myeloma and Other Plasma Cell Disorders

Shaji Kumar, MD, and Sagar Lonial, MD, review key studies and data relevant to the management of patients with multiple myeloma and other plasma cell disorders presented at the 2014 American Society of Hematology Annual Meeting.

Shaji Kumar, MD Sagar Lonial, MD Physicians: maximum of 2.25 AMA PRA Category 1 Credits Released: February 20, 2015 Expiration: February 19, 2016

In this downloadable slideset, Sagar Lonial, MD, and Shaji Kumar, MD, review key studies and data relevant to the management of patients with multiple myeloma and other plasma cell disorders presented at the 2014 American Society of Hematology Annual Meeting.

Released: January 9, 2015
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Educational grant provided by:
Ariad Pharmaceuticals
Celgene Corporation
Novartis Oncology
Onyx Pharmaceuticals
Seattle Genetics

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?